HomeNewsBusinessPassengers testing positive for COVID-19 on arrival: Air India's fault?

Passengers testing positive for COVID-19 on arrival: Air India's fault?

While Hong Kong has barred Air India after its flight carried infected fliers, similar instances have been reported in Wuhan and Dubai

November 04, 2020 / 14:25 IST
Story continues below Advertisement
A woman has a temperature check at Hong Kong airport on April 23, 2004, as a precaution against the SARS virus. (Image: Reuters)
A woman has a temperature check at Hong Kong airport on April 23, 2004, as a precaution against the SARS virus. (Image: Reuters)

Neelima Mahajan and her family were prepared for it. They just landed at the Hong Kong International Airport in their Air India flight from Delhi, on October 8. As was the protocol, officials at the airport took swabs of Neelima, her husband and son to test for COVID-19. Now they had to wait for the results to come before they could head out of the airport.

The wait, they were warned on Facebook groups of people who had already gone through the experience, could be 12-hours long. "We were prepared to the T," says Neelima, who works at a global consultancy in Hong Kong.

Story continues below Advertisement

The family promptly erected a tent at one corner of the waiting area. As her son got comfortable, Neelima took out cups of instant noodles that she had packed. On the Facebook group, many had said only cookies and crackers would be available at the airport. Hot water was for only those who were traveling with infants and young children. "We actually managed to sleep and get rest," she says.

Even as they waited, four fellow passengers were taken away by officials dressed in PPE suits. The four had probably tested positive. This is despite all passengers required to carry a negative-test report before boarding in India.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show